SELECT MEDICAL HOLDINGS CORP — fact timeline

SELECT MEDICAL HOLDINGS CORP reported first quarter ended March 31, 2026 results: revenue $1,421.5 million, net income $63.8 million, EPS $0.35.

“For the first quarter ended March 31, 2026, revenue increased 5.0% to $1,421.5 million, compared to $1,353.2 million for the same quarter, prior year. Income from operations was $98.4 million for the first quarter ended March 31, 2026, compared to $112.7 million for the same quarter, prior year. Net income was $63.8 million for the first quarter ended March 31, 2026, compared to $74.7 million for the same quarter, prior year. Adjusted EBITDA was $141.6 million for the first quarter ended March 31, 2026, compared to $151.4 million for the same quarter, prior year. Earnings per common share was $0.35 for the first quarter ended March 31, 2026, compared to $0.44 for the same quarter, prior year.”

SELECT MEDICAL HOLDINGS CORP: Board adopted Amended and Restated Bylaws enhancing stockholder nomination and proposal procedures, including universal proxy rule compliance requirements (effective 2025-07-30).

“On July 30, 2025, the Board of Directors (the “Board”) of Select Medical Holdings Corporation (the “Company”) approved and adopted amendments to the Company’s bylaws, amending and restating them in their entirety (the “Amended and Restated Bylaws”).”

David S. Chernow was appointed as director at SELECT MEDICAL HOLDINGS CORP.

“On July 31, 2024, the Board of Directors (the “Board”) of the Company appointed David S. Chernow as a director of the Company, effective August 1, 2024, in order to fill the vacancy created by Mr. Ortenzio’s resignation.”

Rocco A. Ortenzio resigned as director at SELECT MEDICAL HOLDINGS CORP.

“Rocco A. Ortenzio, a director of Select Medical Holdings Corporation (the “Company”), notified the Company of his decision to resign as a director, effective August 1, 2024.”

SELECT MEDICAL HOLDINGS CORP reported for its first quarter ended March 31, 2024 results: revenue increased 7.4% to $1,788.8 million, net income increased 37.4% to $117.2 million, EPS increased 33.9% to $0.75.

“SEM) today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend. For the first quarter ended March 31, 2024, revenue increased 7.4% to $1,788.8 million, compared to $1,665.0 million for the same quarter, prior year. Income from operations increased 28.1% to $194.0 million for the first quarter ended March”

SELECT MEDICAL HOLDINGS CORP: Amended certificate of incorporation to permit officer exculpation under Delaware law (effective 2024-04-26).

“The amendment of Charter became effective upon the filing of a certificate of amendment with the Delaware Secretary of State on April 26, 2024.”

SELECT MEDICAL HOLDINGS CORP shareholders approved Non-Binding Advisory Vote on Stockholder’s Simple Majority Proposal.

“Proposal 6 : Non-Binding Advisory Vote on Stockholder’s Simple Majority Proposal Votes For Votes Against Abstentions Broker Non-Votes 74,680,241 46,242,865 23,652 2,545,553”

SELECT MEDICAL HOLDINGS CORP shareholders approved Approval of Amendment to the Company’s Amended and Restated Certificate of Incorporation To Permit the Exculpation of Officers of the Company.

“Proposal 5 : A pproval of Amendment to the Company’s Amended and Restated Certificate of Incorporation To Permit the Exculpation of Officers of the Company Votes For Votes Against Abstentions Broker Non-Votes 116,474,404 4,352,165 119,189 2,545,553”

SELECT MEDICAL HOLDINGS CORP shareholders approved Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024 at the 2024-12-31 meeting.

“Proposal 4 : Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024 Votes For Votes Against Abstentions Broker Non-Votes 122,477,547 987,844 26,920 0”

SELECT MEDICAL HOLDINGS CORP shareholders approved Approval of Amendment to the Company’s 2020 Equity Incentive Plan to Increase the Total Share Reserve and Add a Minimum Vesting Period.

“Proposal 3 : A pproval of Amendment to the Company’s 2020 Equity Incentive Plan to Increase the Total Share Reserve and Add a Minimum Vesting Period Votes For Votes Against Abstentions Broker Non-Votes 119,196,980 1,718,471 31,307 2,545,553”

SELECT MEDICAL HOLDINGS CORP shareholders approved Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers.

“Proposal 2 : Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers Votes For Votes Against Abstentions Broker Non-Votes 106,777,980 14,125,946 42,832 2,545,553”

SELECT MEDICAL HOLDINGS CORP shareholders approved Election of Three Class III Directors to the Board of Directors.

“Proposal 1 : The Election of Three Class III Directors to the Board of Directors Name Votes For Votes Against Abstentions Broker Non-Votes James S. Ely III 102,880,768 18,037,258 28,732 2,545,553 Rocco A. Ortenzio 114,949,540 5,968,478 28,740 2,545,553 Thomas A. Scully 114,375,405 6,542,501 28,852 2,545,553”